BACKGROUND
Chimeric antigen receptor T cell (CAR T) therapies pose challenges for economic evaluation because of complex treatment pathways and uncertainty around long-term outcomes. Within health technology assessment (HTA) bodies such as the National Institute for Health and Care Excellence (NICE), these features hav...
Mehdi Yousefi, Amin Mehrabian, M. O'Reilly et al.· PharmacoEconomics (Auckland)· 0 citations
Childhood vaccine hesitancy remains a significant public health concern, especially as it relates to ethnic minority population in the United Kingdom, who are reluctant to engage in uptake and record a higher number of unvaccinated children. Yet, there remains a significant research gap on the factors driving ethni...
T. Ike, D. E. Jidong, C. Obi et al.· Frontiers in Public Health· 0 citations
Green health prescribing (GHP) refers to nature-based interventions (NBIs) prescribed by a clinician or qualified health or social care professional. Given the ageing global population and increasing care needs posing severe challenges for healthcare systems, GHP has emerged as a potentially effective and efficient sch...
J. Donoghue, Furqan Butt, Cameron D. Ley et al.· BMC Medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.